381
Participants
Start Date
March 29, 2019
Primary Completion Date
December 29, 2019
Study Completion Date
December 29, 2019
ATB-346 low dose
Double blind comparison of orally administered ATB-346 versus placebo in osteoarthritis patients
Placebo
Double blind comparison of orally administered ATB-346 versus placebo in osteoarthritis patients
ATB-346 mid-dose
Double blind comparison of orally administered ATB-346 versus placebo in osteoarthritis patients
ATB-346 standard dose
Double blind comparison of orally administered ATB-346 versus placebo in osteoarthritis patients
Viable Clinical Research Corp, Mission
Ocean West Research Clinic, Surrey
James K. Lai MD Inc, Vancouver
Dr. MB Jones Inc, Victoria
True North Clinical Research Inc., Halifax
Aggarwal and Associates Limited, Brampton
Manna Research (Burlington North), Burlington
Etobicoke Medical Centre, Etobicoke
Dawson Clinical Research, Guelph
Dr. Allen Greenspoon Medicine Professional Corporation, Hamilton
Hamilton Medical Research Group, Hamilton
Milestone Research Inc., London
KGK Science Inc, London
Malton Medical Clinic, Mississauga
SKDS Research Inc, Newmarket
King Street Medical Clinic, Oshawa
Bluewater Clinical Research Group Inc, Sarnia
Viable Clinical Research Corp, Scarborough Village
Dr. Steven V. Zizzo Medicine Professional Corporation, Stoney Creek
Manna Research (Stoney Creek), Stoney Creek
Canadian Phase Onward Inc., Toronto
LMC Clinical Research Inc, Toronto
Manna Research (Toronto), Toronto
Dr. Sabeen Anwar Medicine Professional Corporation, Windsor
Clinical Research& Arthritis Centre, Windsor
Devonshire Clinical Research Inc., Woodstock
Manna Research (Quebec), Lévis
Manna Research (Mirabel QC), Mirabel
Recherche GCP Research, Montreal
Centre Medical Acadie, Montreal
Manna Research (Montreal), Pointe-Claire
Diex Recherche Quebec Inc., Québec
Centre de Recherche Saint-Louis, Québec
Diex Recherche Sherbrooke Inc., Sherbrooke
Diex Recherche Victoriaville Inc., Victoriaville
Lead Sponsor
Veristat, Inc.
OTHER
Antibe Therapeutics Inc.
INDUSTRY